Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-NSCC): Results from the randomized phase II RESGEX study.

被引：4
|
作者：
Keilholz, Ulrich
Kawecki, Andrzej
Dietz, Andreas
Zurawski, Bogdan
Schenker, Michael
Kukielka-Budny, Bozena
Schafhausen, Philippe
Mihailov, Anca C.
Ochenduszko, Sebastian
Imarisio, Ilaria
Mihutiu, Simona
Oprean, Cristina-Marinela
Folprecht, Gunnar
Turcu, Alina
Rottey, Sylvie
Debourdeau, Philippe
Lavernia, Javier
Dietrich, Bruno
Zurlo, Alfredo
Fayette, Jerome
机构：
[1] Charite Comprehens Canc Ctr, Berlin, Germany
[2] M Sklodowska Curie Mem Inst, Canc Ctr, Warsaw, Poland
[3] Univ Leipzig, Leipzig, Germany
[4] F Lukaszczyk Oncol Ctr, Bydgoszcz, Poland
[5] S C Centrul Oncol, Policlin Sf Nectarie, Craiova, Romania
[6] Ctr Oncol, Lublin, Poland
[7] Univ Hamburg Eppendorf, Hamburg, Germany
[8] Univ Hosp Cluj, Cluj Napoca, Romania
[9] Krakow Univ Hosp Oncol Clin, Krakow, Poland
[10] IRCCS San Matteo Univ Hosp Fdn, Dept Med Oncol, Pavia, Italy
[11] Emergency Clin Hosp Oradea, Oradea, Bihor, Romania
[12] ONCOMED SRL, Timisoara, Romania
[13] Univ Hosp Carl Gustav Carus, Dresden, Germany
[14] SPITAL LOTUS SRL, Ploiesti, Romania
[15] Ghent Univ Hosp, Heymans Inst Pharmacol, Ghent, Belgium
[16] Inst Sainte Catherine, Avignon, France
[17] FIVO, Valencia, Spain
[18] Glycotope GmbH, Berlin, Germany
[19] Ctr Leon Berard, Med Oncol, Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期
关键词：
D O I：
10.1200/JCO.2018.36.5_suppl.59
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
59
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CetuGEX and cetuximab in recurrent/metastatic squamous cell carcinoma of the head and neck (RMHNSCC): PK/PD results from the phase II RESGEX study.
    Baumeister, Hans
    Zurlo, Alfredo
    Fayette, Jerome
    Dietrich, Bruno
    Keilholz, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [2] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Tang, Patricia A.
    Siu, Lillian L.
    Chen, Eric X.
    Hotte, Sebastien J.
    Chia, Stephen
    Schwarz, James K.
    Pond, Gregory R.
    Johnson, Caitlin
    Colevas, A. Dimitrios
    Synold, Timothy W.
    Vasist, Lakshmi S.
    Winquist, Eric
    INVESTIGATIONAL NEW DRUGS, 2008, 26 (03) : 257 - 264
  • [3] A Phase II Study of Lapatinib in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    de Souza, Jonas A.
    Davis, Darren W.
    Zhang, Yujian
    Khattri, Arun
    Seiwert, Tanguy Y.
    Aktolga, Serdal
    Wong, Stuart J.
    Kozloff, Mark F.
    Nattam, Sreenivasa
    Lingen, Mark W.
    Kunnavakkam, Rangesh
    Stenson, Kerstin M.
    Blair, Elizabeth A.
    Bozeman, Jeffrey
    Dancey, Janet E.
    Vokes, Everett E.
    Cohen, Ezra E. W.
    CLINICAL CANCER RESEARCH, 2012, 18 (08) : 2336 - 2343
  • [4] Phase II study of ispinesib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Patricia A. Tang
    Lillian L. Siu
    Eric X. Chen
    Sebastien J. Hotte
    Stephen Chia
    James K. Schwarz
    Gregory R. Pond
    Caitlin Johnson
    A. Dimitrios Colevas
    Timothy W. Synold
    Lakshmi S. Vasist
    Eric Winquist
    Investigational New Drugs, 2008, 26 : 257 - 264
  • [5] Paclitaxel and carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck. A phase II study.
    Hiller, S
    Mergenthaler, HG
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 507S - 507S
  • [6] A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
    Seiwert, T. Y.
    Fayette, J.
    Cupissol, D.
    del Campo, J. M.
    Clement, P. M.
    Hitt, R.
    Degardin, M.
    Zhang, W.
    Blackman, A.
    Ehrnrooth, E.
    Cohen, E. E. W.
    ANNALS OF ONCOLOGY, 2014, 25 (09) : 1813 - 1820
  • [7] A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
    Lee, Ji Hyun
    Heo, Seong Gu
    Ahn, Beung-Chul
    Hong, Min Hee
    Cho, Byoung Chul
    Lim, Sun Min
    Kim, Hye Ryun
    CANCER MEDICINE, 2021, 10 (20): : 7012 - 7020
  • [8] A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma
    Gilbert, Jill
    Schell, Michael J.
    Zhao, Xiuhua
    Murphy, Barbara
    Tanvetyanon, Tawee
    Leon, Marino E.
    Hayes, D. Neil
    Haigentz, Missak, Jr.
    Saba, Nabil
    Nieva, Jorge
    Bishop, Justin
    Sidransky, David
    Ravi, Rajani
    Bedi, Atul
    Chung, Christine H.
    ORAL ONCOLOGY, 2015, 51 (04) : 376 - 382
  • [9] A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)
    Limaye, Sewanti
    Riley, Sarah
    Zhao, Sihai
    O'Neill, Anne
    Posner, Marshall
    Adkins, Douglas
    Jaffa, Zachary
    Clark, John
    Haddad, Robert
    ORAL ONCOLOGY, 2013, 49 (08) : 835 - 841
  • [10] Efficacy and safety of penpulimab plus anlotinib in recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): A phase II study
    Shi, Y-K.
    Gao, L.
    Tian, Y.
    Chen, J.
    Wang, J.
    Bai, C.
    Li, X.
    Su, H.
    Liu, Z.
    ANNALS OF ONCOLOGY, 2021, 32 : S806 - S806
12345